In vitro models of the liver : disease modeling, drug discovery and clinical applications

Scott D. Collins, Gloria Yuen, Thomas Tu, Magdalena A. Budzinska, Kevin Spring, Katherine Bryant, Nicholas A. Shackel

Research output: Chapter in Book / Conference PaperChapter

Abstract

In vitro models of the liver have led to important insights into the pathogenesis of liver disease. These models are essential tools in the discovery and preclinical stages of drug development. The clinical application of these models is also emerging as a promising avenue for validating genetic target-matched treatments, in a precision medicine approach to treatment. Recent advances in ‘liver-on-a-chip’ technology and liver organoid research have opened up new opportunities for the functional and clinical use of organotypic in vitro models. This chapter focuses on the currently available in vitro liver models and the opportunities and limitations they present in the context of evaluating their use in disease modeling, drug discovery, and clinical application.
Original languageEnglish
Title of host publicationHepatocellular Carcinoma
EditorsJanina E. E. Tirnitz-Parker
Place of PublicationBrisbane, Qld.
PublisherCodon Publications
Pages47-67
Number of pages21
ISBN (Print)9780994438188
DOIs
Publication statusPublished - 2019

Open Access - Access Right Statement

This open access article is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). https://creativecommons.org/licenses/by-nc/4.0/

Fingerprint

Dive into the research topics of 'In vitro models of the liver : disease modeling, drug discovery and clinical applications'. Together they form a unique fingerprint.

Cite this